Wednesday, June 10, 2026

Patent directory · USPTO A61K / A61P

Patents matching “administration”

271 pharma patents match "administration" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 271
Index total 30,257
Page 2 / 12

Quick answer

This filtered view shows 271 pharmaceutical patents matching "administration" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

271 results for “administration” · 30,257 patents in full index Clear search

  1. US 12097210

    Concomitant administration of glucocorticoid receptor modulators and CYP3A inhibitors

    Corcept Therapeutics Incorporated · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  2. US 12076397

    Emulsion adjuvant for intramuscular, intradermal and subcutaneous administration

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Sep 3, 2024 · Expires Aug 29, 2044

    granted
  3. US 12042487

    Method for reducing side effects from administration of phosphodiesterase-4 inhibitors

    ARCUTIS BIOTHERAPEUTICS, INC. · Granted Jul 23, 2024 · Expires Jul 18, 2044

    granted
  4. US 12016904

    Treatment of gastrointestinal bleeding in patients with severe von Willebrand disease by administration of recombinant VWF

    Takeda Pharmaceutical Company Limited · Granted Jun 25, 2024 · Expires Jun 20, 2044

    granted
  5. US 12005126

    Compositions for oral administration of pentosan polysulfate in form of nanoparticles with improved intestinal absorption

    ALMIRA PHARMA SRL · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted
  6. US 11992480

    Method for reducing side effects from administration of phosphodiesterase-4 inhibitors

    ARCUTIS BIOTHERAPEUTICS, INC. · Granted May 28, 2024 · Expires May 23, 2044

    granted
  7. US 11986446

    Method of administration of gamma hydroxybutyrate with monocarboxylate transporters

    Jazz Pharmaceuticals Ireland Limited · Granted May 21, 2024 · Expires May 16, 2044

    granted
  8. US 11969435

    Concomitant administration of glucocorticoid receptor modulators and CYP3A inhibitors

    Corcept Therapeutics Incorporated · Granted Apr 30, 2024 · Expires Apr 25, 2044

    granted
  9. US 11944617

    Concomitant administration of glucocorticoid receptor modulator relacorilant and paclitaxel, a dual substrate of CYP2C8 and CYP3A4

    Corcept Therapeutics Incorporated · Granted Apr 2, 2024 · Expires Mar 28, 2044

    granted
  10. US 11938192

    Dosage regimes for the administration of an anti-CD19 ADC

    ADC THERAPEUTICS SA · Granted Mar 26, 2024 · Expires Mar 21, 2044

    granted
  11. US 11931459

    Treatment of pain in pediatric patients by administration of sustained-release liposomal anesthetic compositions

    Pacira Pharmaceuticals, Inc. · Granted Mar 19, 2024 · Expires Mar 14, 2044

    granted
  12. US 11931335

    Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof

    Amazentis SA · Granted Mar 19, 2024 · Expires Mar 14, 2044

    granted
  13. US 11931336

    Enhancing autophagy or increasing longevity by administration of urolithins

    Amazentis SA · Granted Mar 19, 2024 · Expires Mar 14, 2044

    granted
  14. US 11918646

    Dry adjuvanted immune stimulating compositions and use thereof for mucosal administration

    The Board of Regents of the University of Texas System · Granted Mar 5, 2024 · Expires Feb 29, 2044

    granted
  15. WO 2024015441

    EXOSOMES DE LAIT BOVIN POUR L'ADMINISTRATION DE VITAMINE K2 ET L'AUGMENTATION DE LA BIODISPONIBILITÉ

    ABBOTT LAB [US] · Granted Jan 18, 2024 · Expires Jan 13, 2044

    granted
  16. US 11851481

    Treatment of central nervous system disorders by intranasal administration of immunoglobulin g

    Takeda Pharmaceutical Company Limited · Granted Dec 26, 2023 · Expires Dec 21, 2043

    granted
  17. US 11819572

    Treatment of pain by administration of sustained-release liposomal anesthetic compositions

    Pacira Pharmaceuticals, Inc. · Granted Nov 21, 2023 · Expires Nov 16, 2043

    granted
  18. US 11801218

    Methods for inducing an immune response via buccal and/or sublingual administration of a vaccine

    The Board of Regents of the University of Texas System · Granted Oct 31, 2023 · Expires Oct 26, 2043

    granted
  19. US 11779635

    Subcutaneous administration of ADAMTS13

    Takeda Pharmaceutical Company Limited · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted
  20. US 11759459

    Treatment of pain by subarachnoid administration of sustained-release liposomal anesthetic compositions

    Pacira Pharmaceuticals, Inc. · Granted Sep 19, 2023 · Expires Sep 14, 2043

    granted
  21. US 11752106

    Pharmaceutical composition and administrations thereof

    Vertex Pharmaceuticals Incorporated · Granted Sep 12, 2023 · Expires Sep 7, 2043

    granted
  22. US 11732024

    VEGF antagonist formulations suitable for intravitreal administration

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted
  23. WO 2023118508

    VIRUS MVA RECOMBINANTS POUR ADMINISTRATION INTRAPÉRITONÉALE POUR LE TRAITEMENT DU CANCER

    BAVARIAN NORDIC AS [DK] · Granted Jun 29, 2023 · Expires Jun 24, 2043

    granted
  24. US 11684597

    Administration of tailored feedstock to increase nitro-containing amphenicol antibiotic susceptibility

    The United States of America as represented by the Secretary of the Army · Granted Jun 27, 2023 · Expires Jun 22, 2043

    granted